A molecular "silencer" makes leukemia cells invisible
The discovery paves the way for new treatments of AML relapses post transplantation
MOREPromising preclinical results for TCR T-cells in AML
The first clinical trial in AML patients, sponsored by Intellia Therapeutics, already began in UK and USA
MORERemoving cancer "sugar shield" improves CAR T efficacy
The layer of sugars surrounding cancer cells plays a key role in protecting them from the immune system
MOREHighlights
Hemorrhagic fevers: bleedings are caused by the inflammatory response to the infection
The research reveals the mechanism behind the most dangerous symptoms caused by hemorrhagic...
Progressive MS: the role of cellular senescence
A five years research project led to a better understanding of the mechanisms underlying the...
A new CT protocol improves differential diagnosis of acute chest pain
Thanks to an innovative imaging technology, physicians were able to improve diagnosis...
Research Highlights
Great research leads to great results. Our pioneering science in numbers.
Research integrity
Upholding high standards of quality, trustworthiness and reproducibility
Industry collaborations
Join the excellence. Explore our integrated biomedical innovation pipeline.
Science outreach
Bridging the gap between science and society, for the benefit of both.